Latent Labs raises £40m Series A led by Radical Ventures and Sofinnova Partners to advance AI protein design

Latent Labs develops AI foundation models for generative protein design, enabling biotech and pharmaceutical teams to computationally design new antibodies, enzymes and therapeutics more efficiently.